Stay updated on Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision banner updated to v3.4.3, replacing the previous v3.4.2 label.SummaryDifference0.1%

- Check58 days agoChange DetectedA new site revision label 'Revision: v3.4.2' was added, and the notice about government funding lapses was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page adds a government funding lapse notice and NIH/OPM status update, and updates the revision to v3.4.1 (replacing the previous v3.4.0).SummaryDifference0.4%

- Check72 days agoChange DetectedThe page adds a glossary toggle, updates and standardizes QC-related labels (Last Update Submitted that Met QC Criteria) and capitalization (No FEAR Act Data), and shows a new revision version (v3.4.0), while removing the older QC label and older revision reference.SummaryDifference0.2%

- Check86 days agoChange DetectedThe page now shows a new revision entry 'Revision: v3.3.4' in the update history, replacing the prior 'Revision: v3.3.3'. This update pertains to version history and does not modify study details or criteria.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.